Providing Today's Patients with Medicines of the Future.
Staff
2017-2019 Net Profit CAGR
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions
On September 3, 2026, Simcere Pharmaceutical Group Limited (02096) announced that Clulevibart Injection (brand name: Inmular?), a domestically develop...
September 1 2026 - Simcere Zaiming ，，，，，a subsidiary of Simcere Pharmaceutical Group today announced that it has entered into an exclusive global licensing...
NANJING, China – August 20, 2026 – Today, Simcere Pharmaceutical Group Limited (2096.HK) announced a strategic partnership with Reyoung (Shandong) Bio...
Recently, the China National Medical Products Administration (NMPA) issued a Drug Registration Certificate (Certificate No. 2026S03082), formally appr...
Telephone: 025-85566666 Fax：025-85262330
Address: 699-18 Xuanwu Avenue Nanjing China
Zipcode：210042
Fax：025-85471729
Su ICP Bei No. 10205883 Su Gong Wang An Bei No. 32010202010345 Su ICP Bei No. 08104641-3 | (Su)–Non-business–2018-0092 (Internet Drug Information Service Qualification Certificate) ? Copyright 2016 Jiangsu Simcere Pharmaceutical Co., Ltd. 版权所有 All Rights Reserved.